⚠ Evidence warning: Clinical trials or other evidence do not support the claims that silicon or silicon-rich mineral water protects arteries, lowers arterial stiffness or cardiovascular events, and clears aluminum to protect heart and brain. This page keeps it as a report of what people, websites or other media say.
Silicon for Cardiovascular Health
In 1979, Jean Loeper and colleagues published an autopsy study in Atherosclerosis that has become the foundational observation of the silicon-cardiovascular literature: silicon content of the human aorta declines progressively with age, and the decline is steepest in segments of aorta showing atherosclerotic plaque. A 2024 review tabulates the paper's human figures by plaque burden: 180 micrograms of silicon per 100 mg of nitrogen with no plaques, 105 with 1–2 plaques and 63 with severe disease. Figures in mg per kg of dry tissue (roughly 200 in healthy young aorta, half that in aging healthy aorta, a quarter or less in atherosclerotic segments) are also reported but could not be confirmed against the paper. This was decades before the modern understanding of silicon's role in elastin cross-linking and arterial wall integrity. Subsequent work by Schwarz, Carlisle, Birchall, Powell, and Davenward has built out the mechanistic picture: silicon is essential for the structural quality of arterial elastin, silicon-rich mineral waters increase urinary aluminum excretion (the Davenward 2013 Alzheimer pilot), and population-level silicon intake from drinking water is reported to correlate inversely with cardiovascular event rates in several large European cohorts. This page walks through the elastin-aorta connection, the bottled-water silicon comparison (the surprising result for high-silica volcanic spring water), and the silicon-arterial-stiffness mechanism that ties the loose-skin and brittle-bones story of silicon deficiency to the harder cardiovascular endpoints.
Table of Contents
- The Loeper 1979 Aortic Silicon Finding
- Elastin Cross-Linking in the Arterial Wall
- Arterial Stiffness, Pulse-Wave Velocity, and Silicon
- Population Data: Silicon Intake and Cardiovascular Events
- Bottled-Water Silicon Concentrations by Type of Water
- Aluminum Clearance via Silicon-Rich Mineral Water (Davenward 2013)
- The Aluminum-Alzheimer-Cardiovascular Crossover
- Vascular Calcification, Silicon, and the K2-D3 Axis
- The Cardiovascular Silicon Protocol Practitioners Describe
- Cautions
- Key Research Papers
- Connections
- Featured Videos
The Loeper 1979 Aortic Silicon Finding
Jean Loeper was a French cardiovascular researcher at the Hopital Boucicaut in Paris who spent much of his career investigating the chemistry of the arterial wall. His 1979 paper in Atherosclerosis (Loeper, Goy-Loeper, Rozensztajn, Fragny: "The antiatheromatous action of silicon") is reported to describe the silicon content of aortic tissue obtained at autopsy from 35 subjects across the age spectrum, stratified by visible atherosclerotic plaque burden. The paper's PubMed abstract describes only its rabbit experiments: silicon, given into a vein or by mouth, inhibited atheroma in rabbits on an atheromatous diet. The full paper could not be read for this page.
A 2024 review (Dudek and colleagues) tabulates the paper's human aorta figures by plaque burden, not age, as silicon per nitrogen:
- No plaques — 180 ± 21 micrograms of silicon per 100 mg of nitrogen.
- Moderate atherosclerosis (1–2 plaques) — 105 ± 12.
- Severe atherosclerosis (numerous plaques and massive lipid infiltrates) — 63 ± 8.
The same review also states that aging markedly reduces silicon in normal human aorta. The following figures are also reported for this autopsy series; their units and age bands could not be confirmed against the paper:
- Young healthy aorta (ages 20-30) — mean silicon content approximately 200 mg/kg dry tissue.
- Older healthy aorta (ages 60-70) — approximately 100 mg/kg, a 50% decline.
- Atherosclerotic aortic plaque segments — approximately 50 mg/kg, a 75% decline relative to young healthy tissue.
- Adjacent uninvolved aortic segments in the same atherosclerotic subjects — intermediate, supporting a local rather than systemic effect.
The interpretation Loeper proposed was that silicon depletion of the arterial wall is permissive of atherosclerotic lesion development — the silicon-impoverished elastin and collagen of aging aorta is less able to resist the mechanical and chemical insults that initiate plaque formation. Loeper went on to conduct a small clinical trial of silicon supplementation in elderly atherosclerotic patients with some clinical improvement, but the trial was uncontrolled by modern standards.
Aortic silicon decline with age in primate models, and similar findings in rabbit aorta with experimental atherosclerosis, are also reported in writing on silicon. The picture some writers draw is that silicon decline is a signature of aortic aging and that the decline is exaggerated in disease.
What is not known: the studies point in more than one direction. A 1985 study of human aortic intima (the inner lining) measured significantly more silicon in fatty streaks and atheroma than in normal intima, and its authors could not say whether this was a cause or a result of the disease. In a 2015 experiment, female mice bred to develop atherosclerosis were fed a high-fat diet with or without silicon for 15–19 weeks. Silicon levels in blood and aorta were lower in the deprived mice, yet fatty lesions, blood lipids and the structure and mechanics of the aorta did not differ, which the authors describe as “contrary to the reported findings in the cholesterol-fed rabbit model.”
Elastin Cross-Linking in the Arterial Wall
The aorta and major arteries have a distinctive three-layer wall structure: tunica intima (innermost, endothelial cell monolayer with a thin subendothelial connective tissue layer), tunica media (the muscular middle layer with concentric elastic laminae), and tunica adventitia (the outer collagen-rich connective tissue sheath). The elastic recoil that allows the aorta to expand with each cardiac systole and contract during diastole (the "Windkessel effect" that smooths pulsatile flow into continuous flow) is provided primarily by the elastic laminae of the tunica media.
Each elastic lamina is a sheet of mature elastin produced from tropoelastin monomers cross-linked by lysyl oxidase into the distinctive desmosine and isodesmosine cross-links unique to elastin. The cross-linking process is critical: poorly cross-linked elastin is mechanically weak and degrades rapidly, while well-cross-linked elastin can last decades. Indeed, the half-life of aortic elastin is estimated at 70 years — the elastin you make as a child must largely last a lifetime, because there is essentially no replacement elastin synthesis in the adult cardiovascular system.
Silicon is concentrated in the elastin-rich segments of arterial wall. Its specific role appears to be twofold:
- Supporting fibrillin-1 microfibril assembly — tropoelastin is deposited onto a scaffold of fibrillin-1 microfibrils. Silicon supports the structural assembly of this scaffold, ensuring that newly synthesized elastin is laid down in proper orientation and density.
- Stabilizing existing elastin cross-links — silicon may form additional structural cross-links between adjacent elastin fibers and between elastin and the surrounding collagen, increasing the overall mechanical integrity of the elastic lamina.
Because adult elastin synthesis is minimal, silicon supplementation in middle and old age cannot create new elastin de novo. But silicon may slow the degradation of existing elastin (by reducing matrix metalloproteinase access) and may improve the function of residual elastin through cross-link stabilization. This explains why silicon-rich diets correlate with lower arterial stiffness even in older adults, when no new elastin is being made.
The implication for prevention is striking: silicon status during childhood, adolescence, and young adulthood — the period when most elastin is laid down — may have outsized effects on cardiovascular outcomes 50 to 70 years later. Children raised on silicon-rich diets (high-grain, mineral-water-rich) may be building a structurally superior elastin scaffold whose mechanical advantages will not become clinically apparent for decades.
Arterial Stiffness, Pulse-Wave Velocity, and Silicon
Arterial stiffness is a measurable consequence of elastin degradation and is itself a strong independent predictor of cardiovascular events. The standard non-invasive measure is carotid-femoral pulse-wave velocity (PWV) — the speed at which the pressure wave generated by left ventricular systole travels from the carotid artery to the femoral artery. Stiffer arteries propagate the pressure wave faster. A normal young adult has PWV of approximately 6 m/s; an 80-year-old typically has PWV of 12-14 m/s. PWV above 10 m/s is associated with substantially increased cardiovascular event risk.
Arterial stiffness drives cardiovascular disease through several mechanisms:
- Isolated systolic hypertension — the stiff aorta cannot absorb the systolic pressure pulse, so systolic blood pressure rises while diastolic falls. This is the typical hypertension pattern of older adults and is the dominant driver of stroke risk.
- Left ventricular hypertrophy — the heart must pump against the stiffer aorta, leading to compensatory wall thickening and ultimately to heart failure with preserved ejection fraction (HFpEF).
- Reduced coronary perfusion — coronary arteries fill during diastole, and reduced diastolic pressure compromises coronary perfusion. This effect is independent of coronary atherosclerosis.
- Increased pulse pressure — the difference between systolic and diastolic pressure widens, and high pulse pressure is itself an independent predictor of stroke and dementia.
Writers on silicon report inverse associations between dietary silicon intake and PWV in middle-aged and older adults. They base a causal interpretation on the role attributed to silicon in maintaining the elastin component of the arterial wall, the principal determinant of arterial compliance.
A randomized, double-blind, placebo-controlled trial appeared in 2025: 120 healthy people aged 60–75 took 3.5 g a day of 1% silicon-enriched spirulina or placebo tablets for 6 months. Across the whole group, no measure differed from placebo. In the subgroup with high-normal blood pressure (systolic 130–150 mmHg) and aortic pulse-wave velocity above 10 m/s, blood pressure fell 8% and pulse-wave velocity 13.5%; people below those cut-offs showed no effect. An employee of the company that supplied the tablets is a co-author.
That subgroup result leaves the question open, so no definitive randomized controlled trial of silicon supplementation for arterial stiffness reduction has been published. This represents a clear research opportunity. Proponents regard the available evidence as enough to include silicon adequacy in comprehensive cardiovascular prevention, but not yet enough to establish silicon supplementation as a stand-alone PWV-lowering intervention.
Population Data: Silicon Intake and Cardiovascular Events
Several European population studies have examined the relationship between drinking-water silicon and cardiovascular outcomes. Drinking water is a tractable population-level silicon exposure because it varies geographically based on local geology and can be quantified relatively easily from public water supply data.
- French studies — writers on silicon describe inverse associations between drinking-water silicon and atherosclerotic events in several French regions, with modest effect sizes that were consistent across multiple analyses. No drinking-water study could be found among the Loeper group's silicon papers.
- Finnish studies — high inter-regional variation in drinking-water silicon (granitic vs sedimentary bedrock) provided natural-experiment data. The record found is a 1977 Lancet report by Schwarz, Ricci, Punsar and Karvonen, “Inverse relation of silicon in drinking water and atherosclerosis in Finland,” a comparison of areas rather than of individual people, with no abstract on PubMed. Inverse associations with cardiovascular mortality are also described for other Finnish cohorts, which could not be traced.
- Cross-national comparisons — populations with traditionally high silicon intake from mineral water (French, Italian, Bavarian) show different cardiovascular risk profiles from populations with lower silicon intake, though such cross-national comparisons are necessarily confounded by many other dietary and lifestyle factors.
Inverse associations between dietary silicon and arterial stiffness markers are also reported in writing on silicon. The Framingham analysis (Jugdaohsingh et al. 2004), a cross-sectional study of 2,847 people, reports on silicon and bone mineral density; its abstract gives no arterial data.
The aggregate observational evidence is suggestive but not definitive. As with any observational nutritional epidemiology, confounding by overall dietary quality, exercise, socioeconomic factors, and other minerals (calcium, magnesium, fluoride) commonly co-varying with silicon in drinking water cannot be fully ruled out. The case for silicon's cardiovascular role rests on the convergence of observational epidemiology, mechanistic biology (elastin, collagen, aluminum clearance), and biomarker outcomes (arterial stiffness, urinary aluminum) rather than on randomized cardiovascular event-rate trials.
Bottled-Water Silicon Concentrations by Type of Water
Mineral waters differ widely in silicon. Selected typical concentrations by type of water (from manufacturer-published mineral analyses, not independently verified except where a study is named; values can drift slightly between batches):
- High-silica volcanic spring water (Pacific island; artesian water from a volcanic aquifer) — 86 mg/L of silica (silicon dioxide) as measured in a 2010 study, and 85–90 mg/L stated in the same paper. Silica is not elemental silicon: by atomic mass that is about 40 mg/L of silicon. This is the highest commonly available bottled water in the US market and is the result of the volcanic geology of its aquifer.
- French volcanic spring water (Auvergne, France; volcanic granitic aquifer) — approximately 30 mg/L silicon. A classic European high-silicon water.
- Southeast Asian silicon-rich mineral water (Malaysia; granitic aquifer) — about 35 mg/L as silicic acid, the figure given in a 2017 study of this water. Widely available in Southeast Asia and increasingly in the US specialty market.
- Italian carbonated mineral water — approximately 6-10 mg/L silicon. Higher in calcium and bicarbonate; modest silicon.
- French sparkling mineral water — approximately 4-7 mg/L silicon. Modest.
- French alpine mineral water — approximately 15 mg/L silicon. Moderate; classic balanced mineral profile.
- Italian still spring water — approximately 12 mg/L silicon. Moderate.
- Tap water — highly variable. Granitic-bedrock municipal supplies (parts of Vermont, parts of Scotland, parts of Bavaria) can reach 15-25 mg/L. Limestone-bedrock supplies (Florida, Texas, much of the US South) typically deliver 2-8 mg/L.
One liter per day of either of the two highest-silicon waters above delivers roughly 35–40 mg of elemental silicon — comparable to the approximately 30 mg a day adults take in from food, according to the 2004 Framingham paper. The cost (the highest-silica water at roughly $2-3 per liter in US grocery stores) is real but not prohibitive for the daily-glass use pattern. People following the Davenward protocol for aluminum clearance tend to choose the higher-silicon waters.
The one randomized trial found of the highest-silica water enrolled 17 postmenopausal women with low bone mass, who drank 1 liter a day of it or of purified water for 12 weeks. Urinary silicon rose significantly in the silica-water group (0.016 to 0.037 mg per mg creatinine) and did not change on purified water, showing that the silicon is absorbed. Markers of bone turnover did not change.
Proponents cite the Loeper observation, the Davenward Alzheimer protocol, and the silicon-bone association as independent lines of evidence for modest daily consumption of high-silicon mineral water for long-term health.
Aluminum Clearance via Silicon-Rich Mineral Water (Davenward 2013)
The 2013 paper by Davenward, Bentham, Wright and colleagues at Keele University (Christopher Exley's group, the most prolific aluminum-toxicity research lab in the world) tested whether dietary silicon could reduce body aluminum burden in patients with Alzheimer's disease. The hypothesis derived from decades of work by Exley's group and others identifying aluminum as a probable contributing factor in Alzheimer's pathology, and from the chemistry that silicic acid forms stable hydroxyaluminosilicate complexes with aluminum ions that are then renally excreted.
The protocol: 15 patients with Alzheimer's disease and a control group of their carers and partners drank up to 1 liter per day of a silicon-rich mineral water (about 35 mg/L as silicic acid, the figure a later study gives for water from the same source) for 12 weeks. Baseline and post-intervention 24-hour urinary aluminum excretion was measured, along with cognitive scores.
The findings:
- Urinary aluminum excretion rose significantly in both groups during the 12-week protocol, confirming that silicon-rich water mobilizes systemic aluminum and increases its renal clearance.
- Cognitive performance showed “clinically relevant improvements in at least 3 out of 15 individuals,” according to the paper's abstract, which calls this preliminary evidence. Accounts of modest improvement in 8 of 15 patients, dramatic improvement in one and others remaining stable rather than declining as expected are not in the abstract, and the full text could not be read.
- No adverse effects from 12 weeks of up to 1 liter/day of this water.
This was a small open-label proof-of-concept study, not a definitive trial. But it was read as evidence that silicon-rich water functions as a non-invasive systemic aluminum chelator at doses achievable from ordinary consumer mineral water consumption. The cardiovascular implication is that the same mechanism — reducing aluminum body burden — may protect arterial wall structure, since aluminum is itself associated with arterial calcification and arterial wall stiffening.
The Exley group later tried the approach in 15 people with secondary progressive multiple sclerosis (also implicated as an aluminum-related condition by the Exley hypothesis), who drank up to 1.5 liters a day for 12 weeks. Urinary aluminum rose from 135.2 to 349.0 nmol per mmol creatinine, and 14 of the 15 excreted more. The comparison was each person's own 12-week baseline, with no separate control group; the paper reports no relapses and no change in disability scores over the 24 weeks. The water's maker partly funded the study and supplied the water. Proponents describe the cumulative case for silicon-rich mineral water as a chronic, low-burden, dietary aluminum-clearance strategy as reasonably robust.
The Aluminum-Alzheimer-Cardiovascular Crossover
The connections between aluminum exposure, Alzheimer's disease, and cardiovascular disease have been built up incrementally over four decades. The summary:
- Aluminum accumulates in the brain with chronic exposure, more so in individuals with reduced renal clearance, and is found in elevated concentrations in Alzheimer plaques.
- Aluminum accumulates in the arterial wall, where it has been shown to interfere with elastin function and to potentiate calcification.
- Aluminum exposure is widespread — antiperspirants, antacids, food additives, vaccine adjuvants, occupational sources, and aluminum cookware all contribute.
- Renal clearance of aluminum is limited — even healthy kidneys excrete only a fraction of absorbed aluminum, and the remainder accumulates in soft tissues over a lifetime.
- Silicon-rich water reduces systemic aluminum in measurable, reproducible quantities.
A French study followed 1,925 people aged 65 or over, free of dementia at the start, for up to 15 years. Each extra 10 mg a day of silica from drinking water went with a lower risk of dementia (adjusted relative risk 0.89, P=0.036), and a daily aluminum intake of 0.1 mg or more from water went with greater cognitive decline (P=0.005) and a higher risk of dementia. Geographic exposure to aluminum or silica from tap water was not associated with dementia. This is an observational finding and does not show cause.
Proponents reason that any chronic exposure-reduction strategy aimed at one of these endpoints (cognitive decline, vascular aging) probably benefits the others. They describe silicon-rich mineral water, going without aluminum antiperspirants and aluminum-containing antacids, and replacing aluminum cookware with stainless steel or cast iron as a low-effort, low-cost package with plausible benefits in both domains.
For more on the cognitive side of this story see our Alzheimer's Disease page; for the broader heavy-metals context see our Aluminum page.
Vascular Calcification, Silicon, and the K2-D3 Axis
One of the modern paradoxes of cardiovascular prevention is that high-dose calcium supplementation may worsen cardiovascular outcomes by promoting vascular calcification, even as it intends to prevent osteoporotic fracture. The Bolland 2010 meta-analysis associated calcium supplements taken without vitamin D with more heart attacks (hazard ratio 1.31, 95% confidence interval 1.02 to 1.67), while its increases in stroke and death were not statistically significant; vitamin K2 was not part of that analysis. Several subsequent studies have also associated calcium supplementation with modest increases in cardiovascular event rates, and proponents hold that the risk is greatest without concurrent vitamin K2.
The proposed mechanism is that excess calcium without adequate K2 to direct it — through carboxylation of osteocalcin (which routes calcium to bone) and matrix Gla protein (which actively inhibits vascular calcification) — ends up in vascular wall calcifications, accelerating arterial stiffening and atherosclerosis. The remedy they describe is twofold: (a) dietary calcium (which is absorbed more gradually and with full cofactor context) in place of high-dose calcium supplements, and (b) adequate vitamin K2 status.
Silicon enters this picture as a third arm of the same axis. Silicon supports the elastin and collagen integrity of the arterial wall, making the wall less susceptible to the calcification process even when calcium is in excess. Silicon thus serves as a brake on vascular calcification analogous to vitamin K2's role — not by directly inhibiting the calcification chemistry, but by preserving the wall structure that resists it.
The integrated cardiovascular protocol that addresses calcium, vitamin D, vitamin K2, magnesium, and silicon together is a more robust prevention strategy than any of these in isolation. This is essentially the same protocol that supports bone density (covered in the Bone Density page) — the bone-cardiovascular overlap is not a coincidence, it reflects the shared connective-tissue biology of both organ systems.
The Cardiovascular Silicon Protocol Practitioners Describe
The items below report what practitioners describe; the doses are theirs.
- Dietary silicon — a target of 25-50 mg/day from food. Daily oatmeal (6-10 mg per bowl), whole-grain breads (3-8 mg per slice), and root vegetables are the baseline they name.
- High-silicon mineral water — 0.5 to 1 liter per day of high-silica volcanic spring water (86 mg/L of silica, about 40 mg/L of silicon), Southeast Asian silicon-rich mineral water (about 35 mg/L), or French volcanic spring water (30 mg/L). Practitioners describe this single intervention as able to double or triple total silicon intake; at these figures one liter adds about 30–40 mg to the approximately 30 mg a day from food.
- Lower aluminum exposure — changing from aluminum-containing antacids (aluminum hydroxide) to calcium carbonate or famotidine; non-aluminum antiperspirant alternatives; stainless steel, glass, or cast iron in place of aluminum cookware, especially for acidic foods (tomato sauce, coffee).
- Co-supplements that support the vascular protocol — vitamin K2 (menaquinone-7, MK-7) 90-180 mcg/day, vitamin D3 to 25(OH)D level 40-60 ng/mL, magnesium 320-420 mg/day, eicosapentaenoic acid (EPA)+docosahexaenoic acid (DHA) omega-3 1-2 g/day.
- Dietary pattern — Mediterranean-style eating emphasizes the whole grains, vegetables, fish, olive oil, and moderate red wine that together support cardiovascular health through multiple mechanisms including silicon adequacy.
- Exercise — aerobic and resistance both reduce arterial stiffness independent of any nutritional intervention. 150 minutes of moderate aerobic activity per week plus 2-3 resistance sessions is the standard target.
- Monitoring with PWV — carotid-femoral pulse-wave velocity is increasingly available in cardiovascular prevention practices and is a useful longitudinal marker of arterial health.
Cautions
- Chronic kidney disease — silicon leaves the body through the kidneys, so the concern with supplements is greatest in chronic kidney disease (CKD) stages 4-5, when kidney clearance is lowest.
- Bottled water environmental cost — high-silicon mineral water typically arrives by container ship from the source country (Pacific islands, France, Southeast Asia). For consumers concerned about plastic waste and carbon footprint, oatmeal and whole grains are a lower-impact silicon source.
- Sodium content in some mineral waters — labels list the sodium content. Some carbonated spa-type mineral waters can be high-sodium; this matters for individuals with salt-sensitive hypertension.
- Aluminum-related interpretation caveats — the Davenward 2013 study was small and open-label. The case for silicon as an aluminum chelator is strong on biochemistry but not yet established at the level of large randomized trials with clinical event outcomes.
- Concurrent medications — vitamin K counteracts warfarin, so adding vitamin K2 to a silicon-based protocol can lower the international normalized ratio (INR) in people taking it.
- Beer caveats — for adults who drink alcohol, beer is the highest-bioavailability silicon source: a study of 76 beers found a mean of 19.2 mg/L silicon, with about 55% absorbed. The cardiovascular harms of alcohol intake above 1-2 drinks per day clearly outweigh any silicon benefit, so this page describes beer as a once-or-twice-per-week dietary source at most, not a daily silicon strategy.
- Pre-existing atherosclerosis — silicon and mineral water are described as adjuncts to, not replacements for, established medical therapy for coronary artery disease, hypertension, or hyperlipidemia. No trial with heart outcomes has tested silicon in place of statins, antihypertensives, or antiplatelet therapy.
This content is provided for informational purposes only and does not constitute medical advice. The safety facts that matter most for a supplement protocol are above: silicon leaves the body through the kidneys, and vitamin K counteracts warfarin.
Key Research Papers
- Loeper J, Goy-Loeper J, Rozensztajn L, Fragny M (1979). The antiatheromatous action of silicon. Atherosclerosis. — PubMed PMID: 508383
- Davenward S, Bentham P, Wright J et al. (2013). Silicon-rich mineral water as a non-invasive test of the 'aluminum hypothesis' in Alzheimer's disease. Journal of Alzheimer's Disease. — PubMed PMID: 22976072
- Schwarz K (1973). A bound form of silicon in glycosaminoglycans and polyuronides. Proceedings of the National Academy of Sciences. — PubMed PMID: 4268099
- Jugdaohsingh R, Tucker KL, Qiao N et al. (2004). Dietary silicon intake is positively associated with bone mineral density in men and premenopausal women of the Framingham Offspring cohort. Journal of Bone and Mineral Research. — PubMed PMID: 14969400
- Birchall JD, Chappell JS (1988). The chemistry of aluminum and silicon in relation to Alzheimer's disease. Clinical Chemistry. — PubMed PMID: 2830051
- Exley C (2009). Darwin, natural selection and the biological essentiality of aluminium and silicon. Trends in Biochemical Sciences. — PubMed PMID: 19773172
- Sripanyakorn S, Jugdaohsingh R, Elliott H et al. (2004). The silicon content of beer and its bioavailability in healthy volunteers. British Journal of Nutrition. — PubMed PMID: 15005826
- Powell JJ, McNaughton SA, Jugdaohsingh R et al. (2005). A provisional database for the silicon content of foods in the United Kingdom. British Journal of Nutrition. — PubMed PMID: 16277785
- Bissé E, Epting T, Beil A et al. (2005). Reference values for serum silicon in adults. Analytical Biochemistry. — PubMed PMID: 15649385
- Bolland MJ, Avenell A, Baron JA et al. (2010). Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. — PubMed PMID: 20671013
- Schurgers LJ, Spronk HMH, Soute BAM et al. (2007). Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood. — PubMed PMID: 17138823
- Virsolvy A, Benmira AM, Allal S et al. (2025). Benefits of dietary supplementation with specific silicon-enriched spirulina on arterial function in healthy elderly individuals: a randomized, placebo-controlled trial. Nutrients. — PubMed PMID: 40077730
- Dudek Ł, Kochman W, Dziedzic E (2024). Silicon in prevention of atherosclerosis and other age-related diseases. Frontiers in Cardiovascular Medicine. — PubMed PMID: 38495942
- Nakashima Y, Kuroiwa A, Nakamura M (1985). Silicon contents in normal, fatty streaks and atheroma of human aortic intima: its relationship with glycosaminoglycans. British Journal of Experimental Pathology. — PubMed PMID: 3970827
- Jugdaohsingh R, Kessler K, Messner B et al. (2015). Dietary silicon deficiency does not exacerbate diet-induced fatty lesions in female ApoE knockout mice. Journal of Nutrition. — PubMed PMID: 25972522
- Schwarz K, Ricci BA, Punsar S, Karvonen MJ (1977). Inverse relation of silicon in drinking water and atherosclerosis in Finland. Lancet. — PubMed PMID: 65628
- Li Z, Karp H, Zerlin A et al. (2010). Absorption of silicon from artesian aquifer water and its impact on bone health in postmenopausal women: a 12 week pilot study. Nutrition Journal. — PubMed PMID: 20946656
- Jones K, Linhart C, Hawkins C, Exley C (2017). Urinary excretion of aluminium and silicon in secondary progressive multiple sclerosis. EBioMedicine. — PubMed PMID: 29128442
- Rondeau V, Jacqmin-Gadda H, Commenges D et al. (2009). Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. American Journal of Epidemiology. — PubMed PMID: 19064650
PubMed Topic Searches
Connections
- All Minerals
- Silicon Overview
- Silicon Benefits Hub
- Silicon for Connective Tissue
- Silicon for Hair and Nails
- Silicon for Bone Density
- Atherosclerosis
- Hypertension
- Alzheimer's Disease
- Aluminum (Toxin)
- Vitamin K2 (Menaquinone-7)
- Vitamin D3
- Magnesium
- Calcium
- Omega-3 Fatty Acids
- Collagen
- Oats (Dietary Silicon)
- Barley
- Deficiency
- Toxicity
- History